Search
Author
- A., Franco-Moreno (1)
- D., Brown-Lavalle (1)
- Hiroki, Matsui (1)
- Hiroyuki, Ohbe (1)
- next >
Subject
Date issued
- 2023 (2)
Has File(s)
- true (2)
Search Results
Current guidelines recommend systemic thrombolysis as the first-line reperfusion treatment for patients with high-risk pulmonary embolism (PE) who present with cardiogenic shock but do not require venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, little is known about the optimal reperfusion treatment in high-risk PE patients requiring VA-ECMO. We aimed to evaluate whether systemic thrombolysis improved high-risk PE patients’ outcomes who received VA-ECMO. |
To compare the severity of pulmonary embolism (PE) and the long-term complications between patients with and without COVID-19, and to investigate whether the tools for risk stratification of death are valid in this population. |